Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Current ratio
Neogen Corporation's current ratio at the end of the quarter to 31 August 2026 was 3.9×, up 0.1× from fiscal 2026 (3.8×). Over the past ten years it has ranged from 3.3× (fiscal 2025) to 11.8× (fiscal 2019); the current reading is higher than 25% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 3.8× | 15.27% |
| FY2025 | 3.3× | (13.17%) |
| FY2024 | 3.8× | (5.20%) |
| FY2023 | 4.0× | (49.98%) |
| FY2022 | 8.1× | (27.03%) |
| FY2021 | 11.0× | (0.44%) |
| FY2020 | 11.1× | (5.69%) |
| FY2019 | 11.8× | 20.99% |
| FY2018 | 9.7× | 19.37% |
| FY2017 | 8.1× | (6.25%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Aug 2026 | 3.9× | 1.95% |
| May 2026 | 3.8× | (2.45%) |
| Feb 2026 | 3.9× | 0.26% |
| Nov 2025 | 3.9× | 9.01% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| AXGN AxoGen, Inc. compare | 12.0× |
| ALMR Alamar Biosciences, Inc. compare | 9.5× |
| INSP Inspire Medical Systems, Inc. compare | 6.4× |
| TMDX TransMedics Group, Inc. compare | 4.5× |
| ITGR Integer Holdings Corporation compare | 4.0× |
| NEOG Neogen Corporation | 3.9× |
| ESTA Establishment Labs Holdings Inc. compare | 3.8× |
| BFLY Butterfly Network, Inc. compare | 3.6× |
| UFPT UFP Technologies, Inc. compare | 3.0× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement